"10.1371_journal.pone.0076523","plos one","2013-10-07T00:00:00Z","Jere E Meredith Jr.; Sethu Sankaranarayanan; Valerie Guss; Anthony J Lanzetti; Flora Berisha; Robert J Neely; J Randall Slemmon; Erik Portelius; Henrik Zetterberg; Kaj Blennow; Holly Soares; Michael Ahlijanian; Charles F Albright","Research and Development, Bristol-Myers Squibb, Wallingford, Connecticut, United States of America; Research and Development, Bristol-Myers Squibb, Lawrenceville, New Jersey, United States of America; Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, University of Gothenburg, MÃ¶lndal, Sweden; UCL Institute of Neurology, London, United Kingdom","Conceived and designed the experiments: JM SS VG AL RS HS MA CA. Performed the experiments: SS VG AL FB RN. Analyzed the data: JM SS VG AL FB RN. Contributed reagents/materials/analysis tools: EP HZ KB. Wrote the manuscript: JM SS VG AL FB RN RS EP HZ KB HS MA CA.","The authors JM, SS, VG, AL, FB, RN, JRS, HS, MA and CA are/were employees of Bristol-Myers Squibb. KB has served on Advisory Boards for Innogenetics (Ghent, Belgium) and Roche (Basel, Switzerland). This work is included in US Patent Application: [PLEASE PROVIDE NAME] and number 61/671,397 (SS, JM, VG). There are no further patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.","2013","10","Jere E Meredith Jr.","JEMJ",13,TRUE,8,5,6,13,TRUE,TRUE,FALSE,0,NA,FALSE
